Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vicore Pharma Holding Major Shareholding Notification 2021

Mar 23, 2021

3211_iss_2021-03-23_c70a1c2d-cc9e-41f8-a633-55090e9f6255.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Vicore Pharma Holding AB

Holder

Handelsbanken Fonder AB

Instrument

Instrument Aktie SE0007577895
Before the transaction
Shares 2,418,696
Voting rights 2,418,696
Transaction
Reason for major shareholding notification Other
Date 19/03/2021
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 3,923,696
Directly held voting rights 3,923,696
Indirectly held voting rights 0
Percentage
Directly held shares 5.47 %
Directly held voting rights 5.47 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.47 % 3,923,696
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.47 % 3,923,696

Group total holdings

Voting rights 3,923,696 Percentage of voting rights 5.47

Notes (other relevant informations according to law)

Flaggning till följd av ökad procentuell andel av antalet aktier och röster mot bakgrund av bolagshändelse. Flaggningen baseras på 71 760 293 utestående aktier i Vicore Pharma.

Published

23/03/2021 15:18

Contact

Name Johanna Lindlöf Phone 08-7012058 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25